New pathogenic paradigms in inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 18, Issue 2, 2012, Pages 368-371

  Di Sabatino, Antonio ^a   Biancheri, Paolo ^b   Rovedatti, Laura ^a   MacDonald, Thomas T ^b   Corazza, Gino R ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Crohn's disease; cytokines; mucosal immunology; T cell; ulcerative colitis

Indexed keywords

ADAPTIVE IMMUNITY; ENTERITIS; INNATE IMMUNITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TH1 CELL; TH17 CELL; TH2 CELL;

ADAPTIVE IMMUNITY; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-17; INTERLEUKIN-23; TH1 CELLS; TH17 CELLS; TH2 CELLS;

EID: 84855672962     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21735     Document Type: Review

References (31)

1. Kaser A, Zeissig S, Blumberg RS,. Inflammatory bowel disease. Annu Rev Immunol. 2010; 28: 573-621.
2. Neurath MF, Finotto S, Glimcher LH,. The role of Th1/Th2 polarization in mucosal immunity. Nat Med. 2002; 8: 567-573. (Pubitemid 34633433)
3. Podolsky DK,. Inflammatory bowel disease. N Engl J Med. 2002; 347: 417-429. (Pubitemid 34851835)
4. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006; 314: 1461-1463. (Pubitemid 44871953)
5. Dubinsky MC, Wang D, Picornell Y, et al. IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease. Inflamm Bowel Dis. 2007; 13: 511-515. (Pubitemid 46799633)
6. Sandborn WJ, Feagan BG, Fedorak RN, et al. A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. Gastroenterology. 2008; 135: 1130-1141.
7. Annunziato F, Cosmi L, Santarlasci V, et al. Phenotypic and functional features of human Th17. J Exp Med. 2007; 204: 1849-1861. (Pubitemid 47240944)
8. Sarra M, Pallone F, Macdonald TT, et al. IL-23/IL-17 axis in IBD. Inflamm Bowel Dis. 2010; 16: 1808-1813.
9. Rovedatti L, Kudo T, Biancheri P, et al. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut. 2009; 58: 1629-1636.
10. Sandborn WJ, Feagan BG, Fedorak RN, et al. A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. Gastroenterology. 2008; 135: 1130-1141.
11. Hueber W, Sands BE, Vandemeulebroecke M, et al. Inhibition of IL-17A by secukinumab is effective in Crohn's disease. J Crohns Colitis. 2011; 5: S7.
12. MacDonald TT, Monteleone G,. Immunity, inflammation, and allergy in the gut. Science. 2005; 307: 1920-1925. (Pubitemid 40404695)
13. Monteleone G, Pallone F, Macdonald TT,. Interleukin-25: a two-edged sword in the control of immune-inflammatory responses. Cytokine Growth Factor Rev. 2010; 21: 471-475.
14. Caruso R, Sarra M, Stolfi C, et al. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. Gastroenterology. 2009; 136: 2270-2279.
15. Rimoldi M, Chieppa M, Salucci V, et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol. 2005; 6: 507-514. (Pubitemid 41716764)
16. Rescigno M, Di Sabatino A,. Dendritic cells in intestinal homeostasis and disease. J Clin Invest. 2009; 119: 2441-2450.
17. Kugathasan S, Saubermann LJ, Smith L, et al. Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease. Gut. 2007; 56: 1696-1705. (Pubitemid 350206296)
18. Xu L, Kitani A, Fuss I, Strober W,. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol. 2007; 178: 6725-6729. (Pubitemid 46847395)
19. Lee YK, Mukasa R, Hatton RD, Weaver CT,. Developmental plasticity of Th17 and Treg cells. Curr Opin Immunol. 2009; 21: 274-280.
20. Abraham C, Cho JH,. Functional consequences of NOD2 (CARD15) mutations. Inflamm Bowel Dis. 2006; 12: 641-650. (Pubitemid 43977746)
21. Lesage S, Zouali H, Cézard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002; 70: 845-857. (Pubitemid 34259301)
22. Wehkamp J, Salzman NH, Porter E, et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A. 2005; 102: 18129-18134. (Pubitemid 41798513)
23. Levine B, Deretic V,. Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol. 2007; 7: 767-777. (Pubitemid 47480305)
24. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007; 39: 207-211. (Pubitemid 46184351)
25. Cadwell K, Liu JY, Brown SL, et al. A key role for autophagy and the autophagy gene Atg16L1 in mouse and human intestinal Paneth cells. Nature. 2008; 456: 259-263.
26. Vetrano S, Rescigno M, Cera MR, et al. Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology. 2008; 135: 173-184. (Pubitemid 351899025)
27. Di Sabatino A, Ciccocioppo R, Luinetti O, et al. Increased enterocyte apoptosis in inflamed areas of Crohn's disease. Dis Colon Rectum. 2003; 46: 1498-1507. (Pubitemid 37429731)
28. Souza HS, Elia CC, Spencer J, et al. Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut. 1999; 45: 856-863.
29. Danese S, de la Motte C, Sturm A, et al. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology. 2003; 124: 1249-1264. (Pubitemid 36531801)
30. Rieder F, Fiocchi C,. Intestinal fibrosis in IBD â a dynamic, multifactorial process. Nat Rev. 2009; 6: 228-235.
31. Di Sabatino A, Jackson CL, Pickard KM, et al. Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures. Gut. 2009; 58: 777-789.